alloClae® for lower body procedures: A Practical, Ultrasound-Guided Approach

Join board-certified plastic surgeon Dr. Johnny Franco, MD, of Austin Plastic Surgeon, for an in-depth look at alloClae®, the allogeneic structural adipose tissue that enables a non-surgical approach to lower body procedures.

As patient demand grows for lasting results without the risks, downtime, and donor-site requirements of traditional fat transfer, alloClae is quickly becoming one of the most requested additions to the aesthetic menu. Dr. Franco will show you how to deliver it safely, predictably, and with confidence.

Dr. Franco will unpack alloClae itself: donor-derived structural adipose tissue comprised of intact adipocytes and extracellular matrix, providing immediate volume and lasting results. alloClae supplements the patient’s own tissue, offering a soft, natural feel and look without the need for liposuction, fat harvesting, or general anesthesia. For patients who are lean, have had a prior BBL, or simply want to avoid the downtime of surgery, alloClae offers a compelling middle ground between temporary fillers and traditional fat transfer.

Dr. Franco will devote significant time to the role of point-of-care ultrasound across the treatment journey. Pre-procedure, he uses ultrasound to assess each patient’s anatomy before ever picking up a cannula: scanning to identify the fascial plane that separates subcutaneous fat from muscle.

No procedure is without risk. Dr. Franco will candidly review the possible complications of gluteal and body contouring applications. He’ll make the case that ultrasound, used both diagnostically before treatment and as real-time guidance during it, gives practitioners an added layer of safety, more predictable and symmetric outcomes, and a documented record of correct plane placement that blind, landmark-based technique simply cannot provide.

Finally, Dr. Franco will get specific about where alloClae fits into a modern aesthetic practice. He’ll highlight the options available to practitioners seeking same-day, in-office treatments that can help meet growing patient demand for nonsurgical solutions that restore volume lost due to aging or GLP-1 medication use and correct contour irregularities following liposuction or weight loss.

Whether you’re a plastic surgeon exploring non-surgical additions to your lower body practice or an aesthetic practitioner looking to expand your body contouring offerings safely, this discussion will provide valuable pearls for how ultrasound can help improve safety and consistency in an efficient way.

Important Safety Information:
alloClae adipose tissue product is intended to be applied subcutaneously in localized areas of the body to provide cushioning and support to the patient’s body where adipose tissue naturally exists. References to contour, restoration, volume replacement, filling soft tissue voids, and similar references describe the consequences of providing such cushioning and support and do not represent separate indications or intended uses. alloClae does not contain viable cells, and has no systemic effect, and is not dependent upon the metabolic activity of living cells for its primary function. alloClae is intended for homologous use only. It is intended for single patient use only. Human tissue shall not be offered or dispensed for veterinary use. alloClae should not be used on patients with severe allergen sensitivities, a history of anaphylaxis, or in the presence of active infection. Like all procedures of this type there is a possibility of complications, although not everyone experiences them. Those potential complications include cystic or nodule formations, pain or infection, hematoma, anaphylaxis or other allergic or immune responses, or discoloration of the skin at the procedure site.

alloClae is a trademark of Tiger Aesthetics Medical, LLC. © 2026 Tiger Aesthetics Medical, LLC. All rights reserved.